iShares MSCI Japan ETF vs Koninklijke Philips NV — how do they compare? iShares MSCI Japan ETF trades at $97.5 (market cap $24.21B), while Koninklijke Philips NV trades at $24.38 (market cap $23.68B). The key difference: iShares MSCI Japan ETF and Koninklijke Philips NV are close in size by market cap, and Koninklijke Philips NV pays a 4.21% dividend while iShares MSCI Japan ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Japan ETF for 56 Days and Koninklijke Philips NV for 84 Days on average.
| EWJ | PHG | |
|---|---|---|
Market Cap | $24.21B | $23.68B |
Volume | 2,672,665 | 1,443,075 |
Sector | Broad Market / Factor | Health |
52-Week High | $99.32 | $32.91 |
52-Week Low | $78.36 | $23.81 |
Typical Hold Time | 56 Days | 84 Days |
Enterprise Value | — | $30.07B |
Dividend Yield | — | 4.21% |
Signals from Pluang's Aura AI — not financial advice
EWJ, the iShares MSCI Japan ETF, trades at $98.32, down 1.01% amid broader Asian market volatility. Technical indicators show a bullish moving average signal but neutral oscillators, with key support at $97 and resistance at $99. Recent news highlights Japan's monetary policy uncertainty as the BOJ navigates rate hikes and yen intervention efforts, creating both opportunities and risks for Japan-focused investors.
The outlook for EWJ remains cautiously optimistic given Japan's economic stimulus efforts and AI sector growth potential, though rising bond yields and currency volatility present significant headwinds. Investors should monitor BOJ policy decisions and yen stability as key catalysts for near-term performance.
PHG trades at $24.30, up 0.62% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong operational cash flow of $1.17B. Analyst consensus leans Hold (63.64%) while institutional activity remains active with recent purchases by Bank of America and Arrowstreet Capital.
The outlook balances recovery momentum against technical weakness. Investment opportunity lies in continued earnings improvement and new product launches, while risks include competitive pressures and the bearish technical trend. Debt levels remain manageable with debt-to-asset ratio at 25.44% as of 2025.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →